These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21619598)

  • 1. Yellow fever virus envelope protein expressed in insect cells is capable of syncytium formation in lepidopteran cells and could be used for immunodetection of YFV in human sera.
    Barros MC; Galasso TG; Chaib AJ; Degallier N; Nagata T; Ribeiro BM
    Virol J; 2011 May; 8():261. PubMed ID: 21619598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 17D yellow fever vaccine virus envelope protein expressed by recombinant baculovirus is antigenically indistinguishable from authentic viral protein.
    Shiu SY; Morikawa S; Buckley A; Higgs S; Karunakarannair V; Blachere C; Gould EA
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1451-4. PubMed ID: 1710651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Characterization of Monoclonal Antibodies to Yellow Fever Virus and Application in Antigen Detection and IgM Capture Enzyme-Linked Immunosorbent Assay.
    Adungo F; Yu F; Kamau D; Inoue S; Hayasaka D; Posadas-Herrera G; Sang R; Mwau M; Morita K
    Clin Vaccine Immunol; 2016 Aug; 23(8):689-97. PubMed ID: 27307452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant baculoviruses expressing yellow fever virus E and NS1 proteins elicit protective immunity in mice.
    Desprès P; Dietrich J; Girard M; Bouloy M
    J Gen Virol; 1991 Nov; 72 ( Pt 11)():2811-6. PubMed ID: 1834798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model.
    Chambers TJ; Liang Y; Droll DA; Schlesinger JJ; Davidson AD; Wright PJ; Jiang X
    J Virol; 2003 Mar; 77(6):3655-68. PubMed ID: 12610141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of yellow fever virus proteins E and NS1 expressed in Vero and Spodoptera frugiperda cells.
    Desprès P; Girard M; Bouloy M
    J Gen Virol; 1991 Jun; 72 ( Pt 6)():1331-42. PubMed ID: 1710649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human antibodies to dengue and yellow fever do not react in diagnostic assays for hepatitis C virus.
    Yoshida CF; Rouzerè CD; Nogueira RM; Lampe E; Travassos-da-Rosa MA; Vanderborght BO; Schatzmayr HG
    Braz J Med Biol Res; 1992; 25(11):1131-5. PubMed ID: 1285268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Investigation of dengue virus and yellow fever virus seropositivities in blood donors from Central/Northern Anatolia, Turkey].
    Ergünay K; Saygan MB; Aydoğan S; Litzba N; Niedrig M; Pınar A; Us D
    Mikrobiyol Bul; 2010 Jul; 44(3):415-24. PubMed ID: 21063991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies.
    Gould EA; Buckley A; Cammack N; Barrett AD; Clegg JC; Ishak R; Varma MG
    J Gen Virol; 1985 Jul; 66 ( Pt 7)():1369-82. PubMed ID: 2410549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant vaccinia virus producing the prM and E proteins of yellow fever virus protects mice from lethal yellow fever encephalitis.
    Pincus S; Mason PW; Konishi E; Fonseca BA; Shope RE; Rice CM; Paoletti E
    Virology; 1992 Mar; 187(1):290-7. PubMed ID: 1736531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of classical swine fever virus envelope glycoprotein E2 as recombinant polyhedra in baculovirus-infected silkworm larvae.
    Lee KS; Sohn MR; Kim BY; Choo YM; Woo SD; Yoo SS; Je YH; Choi JY; Roh JY; Koo HN; Jin BR
    Mol Biotechnol; 2012 Mar; 50(3):211-20. PubMed ID: 21706129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Chimeric Japanese Encephalitis Vaccine Protects against Lethal Yellow Fever Virus Infection without Inducing Neutralizing Antibodies.
    Mishra N; Boudewijns R; Schmid MA; Marques RE; Sharma S; Neyts J; Dallmeier K
    mBio; 2020 Apr; 11(2):. PubMed ID: 32265332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and application of yellow fever virus NS1 protein-specific monoclonal antibodies.
    Liu D; Chen D; Zhang T; Yu N; Ren R; Chen Y; Wang C
    J Med Virol; 2021 Jun; 93(6):3374-3382. PubMed ID: 32841419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses.
    Brandriss MW; Schlesinger JJ; Walsh EE; Briselli M
    J Gen Virol; 1986 Feb; 67 ( Pt 2)():229-34. PubMed ID: 3944585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of bovine immunodeficiency-like virus envelope glycoproteins by a recombinant baculovirus in insect cells.
    Rasmussen L; Greenwood JD; Gonda MA
    Virology; 1992 Feb; 186(2):551-61. PubMed ID: 1310184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species.
    Grifoni A; Voic H; Dhanda SK; Kidd CK; Brien JD; Buus S; Stryhn A; Durbin AP; Whitehead S; Diehl SA; De Silva AD; Balmaseda A; Harris E; Weiskopf D; Sette A
    J Virol; 2020 May; 94(10):. PubMed ID: 32132233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone.
    Jiang X; Dalebout TJ; Lukashevich IS; Bredenbeek PJ; Franco D
    J Gen Virol; 2015 Apr; 96(Pt 4):804-814. PubMed ID: 25516543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in vitro but does not protect a mouse model from disease.
    Calvert AE; Dixon KL; Piper J; Bennett SL; Thibodeaux BA; Barrett AD; Roehrig JT; Blair CD
    Antiviral Res; 2016 Jul; 131():92-9. PubMed ID: 27126613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.
    Guirakhoo F; Zhang Z; Myers G; Johnson BW; Pugachev K; Nichols R; Brown N; Levenbook I; Draper K; Cyrek S; Lang J; Fournier C; Barrere B; Delagrave S; Monath TP
    J Virol; 2004 Sep; 78(18):9998-10008. PubMed ID: 15331733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.